The Foundation for Innovative New Diagnostics (FIND) and Cepheid, Inc, announced today the launch of the new Xpert® MTB/XDR* test, which enables expanded drug-resistance tuberculosis (TB) profiling in less than 90 minutes. Xpert MTB/XDR can be used to emp
A private-public consortium to develop pre-filled syringe packaging has been backed by Jefferies, including a seed capital commitment of at least $10 million.
Tthe Accelerated Access Collaborative (AAC) has announced that Roche Diagnostics tests for suspected pre-eclampsia and heart attack have been recognised as ‘transformative’ ...